04
Nov-2013

Pairwise Affinity

The company’s lead product, the “AMD Vision Test,” measures changes in visual function in people with Age-Related Macular Degeneration. AMD is a devastating eye disease and the leading cause of blindness. In Canada and the US, more than 10 million people over the age of 50 are affected by AMD.

Pharmaceutical companies call AMD a “blockbuster indication” because an effective new drug therapy for early AMD (when sight can still be saved) would be worth billions of dollars a year in new revenue.

 

Share this post:

Archives

> <
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec